Literature DB >> 10790861

7-Nitroindazole blocks nicotine-induced conditioned place preference but not LiCl-induced conditioned place aversion.

J L Martin1, Y Itzhak.   

Abstract

We have shown previously that the neuronal nitric oxide synthase (nNOS) is involved in the rewarding effect of cocaine as determined by the conditioned place preference (CPP) paradigm. In the present study we investigated the effect of the nNOS inhibitor 7-nitroindazole (7-NI) on nicotine-induced CPP and LiCl-induced conditioned place aversion (CPA) in Swiss Webster mice. Mice treated with nicotine (0.5 mg/kg) or saline every other day for 8 days (four drug and four saline sessions) developed CPP that was completely blocked by pretreatment with 7-NI (25 mg/kg). Mice treated with LiCl (150 mg/kg) developed marked aversion to the LiCl-paired compartment. LiCl-induced CPA was not affected by the pretreatment with 7-NI. These findings suggest that nitric oxide (NO) plays a role in the acquisition of reward but not of aversion and that the blockade of nicotine-induced CPP is probably not due to impairment of learning and memory.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10790861     DOI: 10.1097/00001756-200004070-00010

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  16 in total

1.  Age-dependent effects of nicotine on locomotor activity and conditioned place preference in rats.

Authors:  James D Belluzzi; Alex G Lee; Heather S Oliff; Frances M Leslie
Journal:  Psychopharmacology (Berl)       Date:  2004-01-22       Impact factor: 4.530

Review 2.  Mouse models for studying genetic influences on factors determining smoking cessation success in humans.

Authors:  F Scott Hall; Athina Markou; Edward D Levin; George R Uhl
Journal:  Ann N Y Acad Sci       Date:  2012-02       Impact factor: 5.691

3.  Prenatal exposure to cocaine alters the development of conditioned place-preference to cocaine in adult mice.

Authors:  C J Malanga; Martina Pejchal; Barry E Kosofsky
Journal:  Pharmacol Biochem Behav       Date:  2007-06-21       Impact factor: 3.533

4.  Minocycline reduced craving for cigarettes but did not affect smoking or intravenous nicotine responses in humans.

Authors:  Mehmet Sofuoglu; Andrew J Waters; Marc Mooney; Stephanie S O'Malley
Journal:  Pharmacol Biochem Behav       Date:  2008-11-13       Impact factor: 3.533

5.  Critical role of nitric oxide on nicotine-induced hyperactivation of dopaminergic nigrostriatal system: Electrophysiological and neurochemical evidence in rats.

Authors:  Vincenzo Di Matteo; Massimo Pierucci; Arcangelo Benigno; Ennio Esposito; Giuseppe Crescimanno; Giuseppe Di Giovanni
Journal:  CNS Neurosci Ther       Date:  2010-03-25       Impact factor: 5.243

6.  Modulatory effects of Ampicillin/Sulbactam on glial glutamate transporters and metabotropic glutamate receptor 1 as well as reinstatement to cocaine-seeking behavior.

Authors:  Alaa M Hammad; Fawaz Alasmari; Yusuf S Althobaiti; Youssef Sari
Journal:  Behav Brain Res       Date:  2017-06-15       Impact factor: 3.332

7.  Cross state-dependency of learning between tramadol and MK-801 in the mouse dorsal hippocampus: involvement of nitric oxide (NO) signaling pathway.

Authors:  Majid Jafari-Sabet; Shiva Amiri; Ramin Ataee
Journal:  Psychopharmacology (Berl)       Date:  2018-04-21       Impact factor: 4.530

8.  Rewarding properties of sildenafil citrate in mice: role of the nitric oxide-cyclic GMP pathway.

Authors:  Pouya Tahsili-Fahadan; Noushin Yahyavi-Firouz-Abadi; Amir Hossein Orandi; Behnaz Esmaeili; Zahra Basseda; Ahmad Reza Dehpour
Journal:  Psychopharmacology (Berl)       Date:  2006-01-20       Impact factor: 4.530

9.  Counterconditioning During Reconsolidation Prevents Relapse of Cocaine Memories.

Authors:  Koral Goltseker; Lilach Bolotin; Segev Barak
Journal:  Neuropsychopharmacology       Date:  2016-07-29       Impact factor: 7.853

Review 10.  Rodent models of nicotine reward: what do they tell us about tobacco abuse in humans?

Authors:  Laura E O'Dell; Taline V Khroyan
Journal:  Pharmacol Biochem Behav       Date:  2008-12-24       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.